Literature DB >> 8168276

Myocarditis as a complication in scleroderma patients with myositis.

L D Kerr1, H Spiera.   

Abstract

This report describes six diffuse scleroderma (PSS) patients with skeletal muscle myositis accompanied by severe myocarditis, diagnosed by CPK-MB elevation in conjunction with severe left ventricular (LV) hypokinesis. Although the myositis improved with steroid therapy in all patients, those treated with steroids alone died due to progressive LV failure. This experience suggests that the LV dysfunction in PSS patients with myositis may have an inflammatory component. Since the myocarditis may not be clinically apparent initially, it is suggested that CPK-MB fractionation and studies of LV function are undertaken in all PSS patients with myositis. The optimal treatment of this disorder, however, has yet to be determined.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8168276     DOI: 10.1002/clc.4960161212

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  7 in total

Review 1.  Inflammatory myopathies overlapping with systemic sclerosis: a systematic review.

Authors:  Jucier Gonçalves Júnior; Naoki Mugii; Pleiades Tiharu Inaoka; Percival Degrava Sampaio-Barros; Samuel Katsuyuki Shinjo
Journal:  Clin Rheumatol       Date:  2022-02-27       Impact factor: 2.980

Review 2.  Primary heart involvement in systemic sclerosis, from conventional to innovative targeted therapeutic strategies.

Authors:  Arianna Ferlito; Corrado Campochiaro; Alessandro Tomelleri; Lorenzo Dagna; Giacomo De Luca
Journal:  J Scleroderma Relat Disord       Date:  2022-03-24

3.  Clinical and histopathological features of patients with systemic sclerosis undergoing endomyocardial biopsy.

Authors:  Karin A L Mueller; Iris I Mueller; David Eppler; Christine S Zuern; Peter Seizer; Ulrich Kramer; Ina Koetter; Martin Roecken; Reinhard Kandolf; Meinrad Gawaz; Tobias Geisler; Joerg C Henes; Karin Klingel
Journal:  PLoS One       Date:  2015-05-12       Impact factor: 3.240

4.  Silent myocarditis in systemic sclerosis detected by cardiovascular magnetic resonance using Lake Louise criteria.

Authors:  Sophie Mavrogeni; Loukia Koutsogeorgopoulou; Georgia Karabela; Efthymios Stavropoulos; Gikas Katsifis; John Raftakis; Sotiris Plastiras; Michel Noutsias; George Markousis-Mavrogenis; Genovefa Kolovou
Journal:  BMC Cardiovasc Disord       Date:  2017-07-17       Impact factor: 2.298

Review 5.  Sex differences in pulmonary arterial hypertension: role of infection and autoimmunity in the pathogenesis of disease.

Authors:  Kyle A Batton; Christopher O Austin; Katelyn A Bruno; Charles D Burger; Brian P Shapiro; DeLisa Fairweather
Journal:  Biol Sex Differ       Date:  2018-04-18       Impact factor: 5.027

6.  Clinical Outcomes of Myocarditis after Moderate-Dose Steroid Therapy in Systemic Sclerosis: A Pilot Study.

Authors:  Burabha Pussadhamma; Thapanee Tipparot; Naruemol Chaosuwannakit; Ajanee Mahakkanukrauh; Siraphop Suwannaroj; Ratanavadee Nanagara; Chingching Foocharoen
Journal:  Int J Rheumatol       Date:  2020-12-19

7.  A Young Male with Severe Myocarditis and Skeletal Muscle Myositis.

Authors:  Abdalla Ibrahim; Eoghan Meagher; Alexander Fraser; Thomas J Kiernan
Journal:  Case Rep Cardiol       Date:  2018-06-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.